Related Experiment Video
Updated: Aug 10, 2026
Pharmacologic Induction of Epidermal Melanin and Protection Against Sunburn in a Humanized Mouse Model
Published on: September 7, 2013
Inhibition of Dunning tumor growth by melatonin
1Department of Neurobiology, University of Texas Medical School at Houston 77225.
Abstract:
Injections of the pineal hormone melatonin reduced growth and increased doubling time of the R3327H Dunning prostatic adenocarcinoma in the Copenhagen X Fisher rat. This occurred even though testosterone levels (50% of normal) were ostensibly high enough to maintain normal tumor growth. Melatonin may act directly upon the conversion of testosterone to dihydrotestosterone to inhibit tumor growth. Alternatively, a more complicated mechanism may be involved since studies on MCF breast cancer tissue indicate an estrogen requirement for inhibition of growth by melatonin.
Insights
Pineal hormone melatonin injections inhibited growth of a specific rat prostate cancer. This suggests melatonin may directly impact testosterone conversion, affecting tumor progression.
Area of Science:
- Oncology
- Endocrinology
- Pharmacology
Background:
- Prostate adenocarcinoma growth is often influenced by androgens like testosterone.
- The pineal hormone melatonin has demonstrated potential anti-cancer properties in various studies.
- Hormonal regulation of tumor growth, particularly in prostate cancer, remains an area of active research.
Purpose of the Study:
- To investigate the effect of melatonin on the growth of R3327H Dunning prostatic adenocarcinoma in rats.
- To explore the potential mechanisms by which melatonin influences prostate tumor growth, considering hormonal interactions.
Main Methods:
- Administration of melatonin injections to rats bearing R3327H Dunning prostatic adenocarcinoma.
- Monitoring tumor growth rate and doubling time.
- Measurement of serum testosterone levels to assess hormonal status during treatment.
Main Results:
- Melatonin injections significantly reduced tumor growth and increased the doubling time of the prostatic adenocarcinoma.
- Tumor inhibition occurred despite testosterone levels being at 50% of normal, suggesting a mechanism beyond simple androgen deprivation.
- Potential direct inhibition of testosterone to dihydrotestosterone conversion by melatonin was proposed.
Conclusions:
- Melatonin exhibits inhibitory effects on the growth of R3327H Dunning prostatic adenocarcinoma in a rat model.
- The mechanism may involve direct interference with androgen metabolism, specifically the conversion of testosterone to dihydrotestosterone.
- Further research is warranted to elucidate the complex mechanisms, potentially involving interactions with other hormones like estrogen, as suggested by related breast cancer studies.
